Selecta Biosciences, Inc. (SELB): Price and Financial Metrics

SELB POWR Grades

• SELB scores best on the Value dimension, with a Value rank ahead of 95.05% of US stocks.
• SELB's strongest trending metric is Growth; it's been moving down over the last 179 days.
• SELB ranks lowest in Growth; there it ranks in the 8th percentile.

SELB Stock Summary

• Of note is the ratio of SELECTA BIOSCIENCES INC's sales and general administrative expense to its total operating expenses; just 10.22% of US stocks have a lower such ratio.
• Over the past twelve months, SELB has reported earnings growth of -228.18%, putting it ahead of just 6.92% of US stocks in our set.
• Revenue growth over the past 12 months for SELECTA BIOSCIENCES INC comes in at 84.7%, a number that bests 90.04% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to SELECTA BIOSCIENCES INC are QURE, BLCM, RAPT, BPMC, and SGMO.
• SELB's SEC filings can be seen here. And to visit SELECTA BIOSCIENCES INC's official web site, go to selectabio.com.

SELB Valuation Summary

• In comparison to the median Healthcare stock, SELB's price/earnings ratio is 70.59% lower, now standing at 6.5.
• SELB's EV/EBIT ratio has moved up 13.3 over the prior 80 months.

Below are key valuation metrics over time for SELB.

SELB Growth Metrics

Its 3 year revenue growth rate is now at 11731.98%.
• Its 2 year revenue growth rate is now at 1520.31%.
• Its year over year cash and equivalents growth rate is now at -9.54%.

Over the past 33 months, SELB's revenue has gone up $117,242,000.

The table below shows SELB's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	123.919	-51.242	41.725
2022-06-30	127.636	-66.341	31.724
2022-03-31	108.026	-60.113	27.688
2021-12-31	85.077	-60.382	-25.687
2021-09-30	67.091	-36.172	-53.372
2021-06-30	47.31	40.211	-45.207

SELB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SELB has a Quality Grade of B, ranking ahead of 76.01% of graded US stocks.
• SELB's asset turnover comes in at 0.269 -- ranking 167th of 682 Pharmaceutical Products stocks.
• QGEN, ALPN, and TXMD are the stocks whose asset turnover ratios are most correlated with SELB.

The table below shows SELB's key quality metrics over time.